Literature DB >> 20029462

Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.

Carlo Selmi1, Francesca Meda, Anaid Kasangian, Pietro Invernizzi, Zhigang Tian, Zhexiong Lian, Mauro Podda, M Eric Gershwin.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease for which an autoimmune pathogenesis is supported by clinical and experimental data, including the presence of autoantibodies and autoreactive T cells. The etiology remains to be determined, yet data suggest that both a susceptible genetic background and unknown environmental factors determine disease onset. Multiple infectious and chemical candidates have been proposed to trigger the disease in a genetically susceptible host, mostly by molecular mimicry. Most recently, several murine models have been reported, including genetically determined models as well as models induced by immunization with xenobiotics and bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029462      PMCID: PMC4003255          DOI: 10.1038/cmi.2009.104

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  99 in total

Review 1.  Molecular mimicry and primary biliary cirrhosis: premises not promises.

Authors:  J Van de Water; H Ishibashi; R L Coppel; M E Gershwin
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

2.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity.

Authors:  Pier Luigi Meroni
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

4.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  X chromosome monosomy: a common mechanism for autoimmune diseases.

Authors:  Pietro Invernizzi; Monica Miozzo; Carlo Selmi; Luca Persani; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Pier Luigi Meroni; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Francesca R Grati; Giuseppe Simoni; M Eric Gershwin; Mauro Podda
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.

Authors:  Gideon M Hirschfield; Xiangdong Liu; Chun Xu; Yue Lu; Gang Xie; Yan Lu; Xiangjun Gu; Erin J Walker; Kaiyan Jing; Brian D Juran; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Catalina Coltescu; Elizabeth J Atkinson; E Jenny Heathcote; Konstantinos N Lazaridis; Christopher I Amos; Katherine A Siminovitch
Journal:  N Engl J Med       Date:  2009-05-20       Impact factor: 91.245

8.  Lack of evidence for leukocyte maternal microchimerism in primary biliary cirrhosis.

Authors:  Kenichi Nomura; Yoshio Sumida; Takaharu Yoh; Atsuhiro Morita; Yosuke Matsumoto; Sawako Taji; Naohisa Yoshida; Masahito Minami; Yoshito Itoh; Shigeo Horiike; Keisho Kataoka; Masafumi Taniwaki; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

9.  Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.

Authors:  Monica Miozzo; Carlo Selmi; Barbara Gentilin; Francesca R Grati; Silvia Sirchia; Sabine Oertelt; Massimo Zuin; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

10.  The genetic basis of primary biliary cirrhosis: premises, not promises.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

View more
  20 in total

1.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

2.  Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics.

Authors:  Toshihiro Tanaka; Weici Zhang; Ying Sun; Zongwen Shuai; Asiya Seema Chida; Thomas P Kenny; Guo-Xiang Yang; Ignacio Sanz; Aftab Ansari; Christopher L Bowlus; Gregory C Ippolito; Ross L Coppel; Kazuichi Okazaki; Xiao-Song He; Patrick S C Leung; M Eric Gershwin
Journal:  Hepatology       Date:  2017-07-20       Impact factor: 17.425

3.  Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Authors:  Jesús M Banales; Elena Sáez; Miriam Uriz; Sarai Sarvide; Aura D Urribarri; Patrick Splinter; Pamela S Tietz Bogert; Luis Bujanda; Jesús Prieto; Juan F Medina; Nicholas F LaRusso
Journal:  Hepatology       Date:  2012-07-10       Impact factor: 17.425

4.  In situ mass spectrometry of autoimmune liver diseases.

Authors:  Christopher L Bowlus; Erin H Seeley; Joanna Roder; Julia Grigorieva; Heinrich Roder; Richard M Caprioli; Meric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

5.  Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.

Authors:  Yin-Hu Wang; Wei Yang; Jing-Bo Yang; Yan-Jie Jia; Wei Tang; M Eric Gershwin; William M Ridgway; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2015-02-17       Impact factor: 7.094

6.  Expression of antisense of microRNA-26a-5p in mesenchymal stem cells increases their therapeutic effects against cirrhosis.

Authors:  Li Chen; Wenhuan Zeng; Bo Yang; Xiang Cui; Cong Feng; Lili Wang; Hao Wang; Xuan Zhou; Peng Li; Faqin Lv; Tanshi Li
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

7.  Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells.

Authors:  Zhi-Bin Zhao; Fang-Ting Lu; Hong-Di Ma; Yin-Hu Wang; Wei Yang; Jie Long; Qi Miao; Weici Zhang; Zhigang Tian; William M Ridgway; Jie Cao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 8.  Autoimmunity and environment: am I at risk?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Harold Baum; Andrew K Burroughs; Diego Vergani; Dimitrios P Bogdanos
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  The latest research trends in primary biliary cholangitis: a bibliometric analysis.

Authors:  Yu Zhao; Zhenjie Yin; Huang Du; Kangming Huang; Fajing Zhang; Hongbin Chen
Journal:  Clin Exp Med       Date:  2022-04-07       Impact factor: 3.984

10.  Primary biliary cirrhosis associated with Graves' disease in a male patient.

Authors:  Yuji Suzuki; Kazuyuki Ishida; Hiroshi Takahashi; Norihiko Koeda; Keisuke Kakisaka; Yasuhiro Miyamoto; Akiko Suzuki; Yasuhiro Takikawa
Journal:  Clin J Gastroenterol       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.